The short version
14 companies supply this market — deep enough that no single failure threatens the supply. The generic price has fallen 45% in a year, to $7.34 per mL — and generics that get this cheap tend to get abandoned rather than defended. The brand (Latisse) runs $103.01 per mL — 12× more. One of its named manufacturing plants, Eugia Pharma Specialities Limited, failed FDA inspectionwithin the last two years — the agency’s most serious outcome. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.